2018
DOI: 10.14814/phy2.13912
|View full text |Cite
|
Sign up to set email alerts
|

Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice

Abstract: We investigated the potential adverse effects of hyperaldosteronism and/or hypoestrogenism on cardiac phenotype, and examined their combined effects in female mice overexpressing cardiac aldosterone synthase (AS). We focused on some signaling cascades challenging defensive responses to adapt and/or to survive in the face of double deleterious stresses, such as Ca2+‐homeostasis, pro/anti‐hypertrophic, endoplasmic reticulum stress (ER stress), pro‐ or anti‐apoptotic effectors, and MAP kinase activation, and redo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 116 publications
0
8
0
Order By: Relevance
“…11 Estradiol treatment in these OVX-DS/obese rats attenuated hypertension and obesity but did not improve heart function because of exacerbated LV fibrosis and diastolic dysfunction, probably mediated by MR activation. 11 On the other hand, in mice with ovariectomy, Rouet-Benzineb et al measured reduced LV protein expression of oestrogen receptor ER-α and ER-β while showing augmented protein expression of cardiac MR. 12 Although a theoretical enhancement of ER activity could be hypothesized at least via indirect mechanisms, for example, counter-regulation of endogenous steroid hormone release by an unselective receptor profile as demonstrated for spironolactone 44 or recruitment of the transcriptional co-activator steroid receptor coregulatory-1 (Src-1), which is shared by most steroid hormone receptors, we have no reason to believe that such indirect mechanisms apply to the benefits of finerenone in the current study. Indeed, (i) finerenone does not have any detectable affinity for both ERα and ERβ, 45 and (ii) finerenone has been demonstrated to act as an inverse agonist for Src-1 recruitment (i.e.…”
Section: Discussionmentioning
confidence: 73%
See 4 more Smart Citations
“…11 Estradiol treatment in these OVX-DS/obese rats attenuated hypertension and obesity but did not improve heart function because of exacerbated LV fibrosis and diastolic dysfunction, probably mediated by MR activation. 11 On the other hand, in mice with ovariectomy, Rouet-Benzineb et al measured reduced LV protein expression of oestrogen receptor ER-α and ER-β while showing augmented protein expression of cardiac MR. 12 Although a theoretical enhancement of ER activity could be hypothesized at least via indirect mechanisms, for example, counter-regulation of endogenous steroid hormone release by an unselective receptor profile as demonstrated for spironolactone 44 or recruitment of the transcriptional co-activator steroid receptor coregulatory-1 (Src-1), which is shared by most steroid hormone receptors, we have no reason to believe that such indirect mechanisms apply to the benefits of finerenone in the current study. Indeed, (i) finerenone does not have any detectable affinity for both ERα and ERβ, 45 and (ii) finerenone has been demonstrated to act as an inverse agonist for Src-1 recruitment (i.e.…”
Section: Discussionmentioning
confidence: 73%
“…On the other hand, in mice with ovariectomy, Rouet‐Benzineb et al . measured reduced LV protein expression of oestrogen receptor ER‐α and ER‐β while showing augmented protein expression of cardiac MR 12 …”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations